Bahamdain, Foud O. 2022. “Retracted: Effect of Dolutegravir on Plasma Glucose Among Human Immunodeficiency Virus Patients in a Community Health Center Setting”. International Journal Of Community Medicine And Public Health 9 (3):1178-82. https://doi.org/10.18203/2394-6040.ijcmph20220673.